Finance

Lists
Why is OTLK up 3,13%?
Dive Deeper
OTLK:NASDAQ
Outlook Therapeutics Inc
0,59 US$
+3,13%
(+0,018) 1D
0,60 US$
+0,83% (+0,0049)
After hours
Closed: 2 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
0,59 US$
High
0,61 US$
Low
0,57 US$
Mkt. cap
145,63 მლნ.
Avg. vol.
5,97 მლნ.
Volume
5,62 მლნ.
52-wk high
2,54 US$
52-wk low
0,16 US$
EPS
-0,87 US$
Beta
0,66
Shares outstanding
243,45 მლნ.
No. of employees
17
Open
0,59 US$
High
0,61 US$
Low
0,57 US$
Mkt. cap
145,63 მლნ.
Avg. vol.
5,97 მლნ.
Volume
5,62 მლნ.
52-wk high
2,54 US$
52-wk low
0,16 US$
EPS
-0,87 US$
Beta
0,66
Shares outstanding
243,45 მლნ.
No. of employees
17
News stories
From web sources and news partners
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
Sector-
Websiteoutlooktherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to OTLK in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OTLK in the last 3 months.
Highest
Current 0,59 US$
10,50 US$ (+1 670,66%)
Average
5,37 US$ (+805,56%)
Lowest
1,60 US$ (+169,81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
10,50 US$
+1 670,7%
09/10/2026
Julian Harrison
BTIG
Buy
Reiterated
4,00 US$
+574,5%
08/14/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
1,60 US$
+169,8%
07/28/2026
Daniil Gataulin
Chardan Capital
Hold
Maintained
1,00 US$
+68,6%
01/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-91,79 ათ.
-1,21 მლნ.
127,44 ათ.
8,70 ათ.
Cost of goods sold
916,52 ათ.
29,63 ათ.
149,33 ათ.
16,96 ათ.
Cost of revenue
916,52 ათ.
29,63 ათ.
149,33 ათ.
16,96 ათ.
Research and development expenses
5,98 მლნ.
3,63 მლნ.
4,50 მლნ.
3,25 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,33 მლნ.
8,61 მლნ.
9,50 მლნ.
7,55 მლნ.
Operating expense
16,31 მლნ.
12,25 მლნ.
14,01 მლნ.
10,80 მლნ.
Total operating expenses
17,22 მლნ.
12,28 მლნ.
14,15 მლნ.
10,82 მლნ.
Operating income
-17,31 მლნ.
-13,48 მლნ.
-14,03 მლნ.
-10,81 მლნ.
Other non operating income
3,02 მლნ.
-2,79 მლნ.
6,84 მლნ.
-7,04 მლნ.
EBT including unusual items
-14,85 მლნ.
-23,06 მლნ.
-4,45 მლნ.
-20,32 მლნ.
EBT excluding unusual items
-14,51 მლნ.
-16,31 მლნ.
-7,23 მლნ.
-17,89 მლნ.
Income tax expense
-1,55 მლნ.
-
-
-
Effective tax rate
10,47%
-
-
-
Other operating expenses
-
-
-
-
Net income
-13,29 მლნ.
-23,06 მლნ.
-4,45 მლნ.
-20,32 მლნ.
Net profit margin
14 482,19%
1 909,05%
-3 494,28%
-233 554,85%
Earnings per share
-0,29
-0,22
-0,17
-0,09
Interest and investment income
89,74 ათ.
-
3,00
7,00
Interest expense
-264,16 ათ.
-
-
-
Net interest expenses
-174,42 ათ.
-
3,00
7,00
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,28 მლნ.
-13,45 მლნ.
-14,00 მლნ.
-10,80 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები